NOVATO, Calif., June 20, 2025 - Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) has announced the grant of 48,731 restricted stock units to 26 newly hired non-executive officers as part of its Ultragenyx Employment Inducement Plan. The awards, approved by the company's board of directors' compensation committee, are intended as a material inducement for the new employees joining the company. These restricted stock units will vest over a period of four years, with 25% of the shares vesting annually on the anniversary of the grant date, provided the employees remain continuously employed with Ultragenyx.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.